Cargando…
The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
BACKGROUND: In cardiovascular disease prevention, low-density lipoprotein cholesterol (LDL-C) values guide treatment for lowering cholesterol level. After 50 years of clinical laboratories using the Friedewald LDL-C equation, the Canadian Society of Clinical Chemists recently recommended adoption of...
Autores principales: | Zhao, Pei Jun, Hegele, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869357/ https://www.ncbi.nlm.nih.gov/pubmed/36700190 http://dx.doi.org/10.1016/j.cjco.2022.09.007 |
Ejemplares similares
-
Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022) -
Validation of low-density lipoprotein cholesterol equations in pediatric population
por: Ertürk Zararsız, Gözde, et al.
Publicado: (2023) -
Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021) -
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020) -
Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations
por: Sampson, Maureen, et al.
Publicado: (2022)